Roche
Roche obesity drug produces 15.5% weight loss in mid-stage trial
Roche says its experimental once-weekly obesity treatment reduced body weight by an average 15.5% after 48 weeks in overweight or obese people with type 2 diabetes. Analysts called the mid-stage results competitive but stressed that larger Phase 3 trials are still needed.
about 3 hours ago · 1 source
